Table 4.
SoC | Belimumab | Difference | |
---|---|---|---|
Life years | 18.99 | 19.76 | 0.77 |
QALYs | 10.78 | 11.31 | 0.538 |
Costs | €125,234 | €142,921 | €17,688 |
ICUR | €32,859 | ||
ICER | €22,990 |
SoC: standard of care; QALY: quality adjusted life year; ICUR: incremental cost-utility ratio; ICER: incremental cost-effectiveness ratio.